Jiangsu Aidea Pharmaceutical Group Co., Ltd.

Jiangsu Aidea Pharmaceutical develops, produces, and sells pharmaceutical products in China and globally. It offers anti-HIV drugs and human-derived proteins, as well as anti-virus products, such as ainuovirine tablets.

Its portfolio also includes urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase, sennae folium granules, and baicillus cereus tablets.

It also exports its products. Founded in 2009 and headquartered in Yangzhou, China, Jiangsu Aidea Pharmaceutical was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. before rebranding in July 2025.